Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area

Dermatology and Therapy · Published 2026-07-22 · DOI 10.1007/s13555-026-01863-2

Free full text

Authors (47)

Gianluca Avallone, Flavia Manzo Margiotta, Andrea Bombelli, Luigi Gargiulo, Caterina Foti, Ilaria Trave, Mariateresa Rossi, Elisabetta Magnaterra, Flavia Pigliacelli, Piergiorgio Malagoli, Serena Giacalone, Antonio Portarapillo, Cataldo Patruno, Natale Schettini, Laura Bonzano, Elena Pezzolo, Camilla Chello, Niccolò Gori, Giovanna Brunasso, Federica Veronese, Michela Ortoncelli, Ersilia Tolino, Alan Azzolini, Francesco Bellinato, Katharina Hansel, Eugenia Veronica Di Brizzi, Carlotta Gurioli, Maria Esposito, Roberta Giuffrida, Francesca Barei, Paolo Calzari, Anna G. Burroni, Massimo Gola, Maria Mariano, Maria Concetta Fargnoli, Maddalena Napolitano, Teresa Grieco, Ketty Peris, Paola Savoia, Simone Ribero, Giampiero Girolomoni, Luca Stingeni, Anna Balato, Antonio Costanzo, Angelo Valerio Marzano, Alessandra Narcisi, Silvia Mariel Ferrucci

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Avallone, G., Margiotta, F., Bombelli, A., et al. (2026). Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area. Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01863-2

Related articles

• Consensus Recommendations for Management of Darier Disease: A Practical Approach · Dermatology and Therapy · 2026 · Same journal
• Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy · Dermatology and Therapy · 2026 · Same journal
• Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension · Dermatology and Therapy · 2026 · Same journal
• Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice Experiment · Dermatology and Therapy · 2026 · Same journal
• JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study · Dermatology and Therapy · 2026 · Same journal
• Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo · Dermatology and Therapy · 2026 · Same journal
• Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study · Dermatology and Therapy · 2026 · Same journal
• Itch, Scratching, and Sleep Mediate the Association between Disease Severity and Quality of Life in Pruritic Dermatoses: A Cross-Sectional Study · Dermatology and Therapy · 2026 · Same journal
• Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region · Dermatology and Therapy · 2026 · Same journal
• Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival · Dermatology and Therapy · 2026 · Same journal